Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 7, 1998 - Issue 8
Submit an article Journal homepage
32
Views
7
CrossRef citations to date
0
Altmetric
Miscellaneous

Low molecular weight heparin in acute stroke

Philip MW Bath Division of Stroke Medicine, University of Nottingham, University Hospital, Queen’s Medical Centre, Nottingham, NG7 2UH, UK. Tel: +44 (0)115 924 9924 x42977; Fax: +44 (0)115 962 7992; Email: [email protected]
Pages 1323-1330 | Published online: 23 Feb 2005

Bibliography

  • BATH PMW: The medical management of stroke. Int..). Pract. (1997) 51:504–510.
  • OPPENHEIMER S, HACHINSKI V: Complications of acute stroke. Lancet (1992) 339:721–724.
  • BATH PMW: Treating acute ischaemic stroke. Br. Med. J. (1995) 311:139–140.
  • STROKE UNIT TRIALISTS' COLLABORATION: Collabora-tive systematic review of the randomised trials of or-ganised inpatient (stroke unit) care after stroke. Br. Med. J. (1997) 314:1151–1159.
  • THE NATIONAL INSTITUTE OF NEUROLOGICAL DISOR-DERS AND STROKE RT-PA STROKE STUDY GROUP: Tis-sue plasminogen activator for acute stroke. New Engl. J. Med. (1995) 333:1581–1587.
  • WARDLAW J, YAMAGUCHI T, DEL ZOPPO G: Throm-bolytic therapy versus control in acute ischaemic stroke. In: The Cochrane Library (Issue 2). Oxford, UK (Up-date Software 1998).
  • MULTICENTRE ACUTE STROKE TRIAL-ITALY (MAST-I) GROUP: Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet (1995) 346:1509–1514.
  • INTERNATIONAL STROKE TRIAL COLLABORATIVE GROUP: The International Stroke Trial (1ST); a ran-domised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet (1997) 349:1569–1581.
  • CAST (CHINESE ACUTE STROKE TRIAL) COLLABORATIVE GROUP: CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischae-mic stroke. Lancet (1997) 349: 1641-1649.
  • BATH PMW: Is stroke a medical emergency? Br. J. Car-dial (1997) 4:88–90.
  • TURPIE AGG, LEVINE MN, HIRSH J et al.: Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet (1987) 1:523–526.
  • KAY R, WONG KS, YU YL et al.: Low-molecular-weight heparin for the treatment of acute ischemic stroke. New Engl. J. Med. (1995) 333:1588–1593.
  • LEIZOROVICZ A, HAUGH MC, CHAPUIS FR, SAMAMA MM, BOISSEL JP: Low molecular weight heparin in preven-tion of perioperative thrombosis. Br. Med. J. (1992) 305:913–920.
  • LEIZOROVICZ A, SIMONNEAU G, DECOUSUS G: Com-parison of efficacy and safety of low molecular weight heparins: a meta-analysis. Br. Med. J. (1994) 309:299–304.
  • LENSING WA, PRINS MH, DAVIDSON BL, HIRSH J: Treat-ment of deep venous thrombosis with low-molecular- weight heparins. A meta analysis. Arch. Intern. Med. (1995) 155:601–607.
  • SIRAGUSA S, COSMI B, PIOVELLA F, HIRSH J, GINSBERG JS: Low-molecular-weight heparins and unfraction-ated heparin the the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am. J. Med. (1996) 100:269–277.
  • VALETTE F, HOFFMEYER U, LLOYD A: Economic evalua-tion of the use on tinzaparin in the treatment of deep vein thrombosis. Br. J. Med. Econ. (1995) 8:111–123.
  • KOOPMAN MMW, PRANDONI P, PIOVELLA F et al: Treat-ment of venous thrombosis with intravenous unfrac-tionated heparin adminstered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. New Engl. J. Med. (1996) 334:682–687.
  • LEVINE M, HIRSH J, LECLERC J et al.: A comparison of low-molecular-weight heparin administered primar-ily at home with unfractionated heparin adminstered in the hospital for proximal deep-vein thrombosis. New Engl. J. Med. (1996) 334:677–681.
  • SIMONNEAU G, SORS H, CHARBONNIER B et al.: A com-parison of low-molecular-weight heparin with unfrac-tionated heparin for acute pulmonary embolism. New Engl. J. Med. (1997) 337:663–669.
  • FRAGMIN DURING INSTABILITY IN CORONARY ARTERY DISEASE (FRISC) STUDY GROUP: Low-molecular-weight heparin during instability in coronary artery disease. Lancet (1996) 347:561–568.
  • COHEN M, DEMERS C, GURFINKEL EP et al.: A compari-son of low-molecular-weight heparin with unfraction-ated heparin for unstable coronary artery disease. New Engl. J. Med. (1997) 337:447–452.
  • PREMMEREUR J: The use of low-molecular-weight heparins in cardiology. In: New Anticoagulants for the Cardiovascular Patient. Pifarre R (Ed.), Hanley & Belfus, Philadelphia, USA (1997):597–608.
  • WOOD JJ: Drug therapy - low molecular-weight hepar-ins. New Engl. J. Med. (1997) 4:688–698.
  • MARSHALL J, SHAW DA: Anticoagulant therapy in acute cerebrovascular accidents: a controlled trial. Lancet (1960) 1:995–998.
  • CARTER AB: Anticoagulant treatment in progressing stroke. Br. Med. J. (1961) ii:70–73.
  • FISHER CM: Anticoagulant therapy in cerebral throm-bosis and cerebral embolism. A national cooperative study, interim report. Neurology (1961) 11:119–131.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.